What to do when two oral agents fail to control type 2 diabetes–a matter of opinion or a matter of fact?
- 15 February 2004
- journal article
- editorial
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (4) , 276-278
- https://doi.org/10.1016/j.amjmed.2003.11.012
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trialThe American Journal of Medicine, 2004
- Glycemic control with Glyburide/Metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trialThe American Journal of Medicine, 2004
- The Treat-to-Target TrialDiabetes Care, 2003
- Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral DrugsDiabetes Care, 2003
- Oral combination therapy for type 2 diabetesDiabetes/Metabolism Research and Reviews, 2002
- Oral Antihyperglycemic Therapy for Type 2 DiabetesJAMA, 2002
- Troglitazone and Liver Function AbnormalitiesDrug Safety, 2001
- Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)JAMA, 1999
- Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Efficacy of Bedtime NPH Insulin With Daytime Sulfonylurea for Subpopulation of Type II Diabetic SubjectsDiabetes Care, 1989